These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 15806168

  • 1. Gli1 is important for medulloblastoma formation in Ptc1+/- mice.
    Kimura H, Stephen D, Joyner A, Curran T.
    Oncogene; 2005 Jun 09; 24(25):4026-36. PubMed ID: 15806168
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation.
    Park HL, Bai C, Platt KA, Matise MP, Beeghly A, Hui CC, Nakashima M, Joyner AL.
    Development; 2000 Apr 09; 127(8):1593-605. PubMed ID: 10725236
    [Abstract] [Full Text] [Related]

  • 6. Altered neural cell fates and medulloblastoma in mouse patched mutants.
    Goodrich LV, Milenković L, Higgins KM, Scott MP.
    Science; 1997 Aug 22; 277(5329):1109-13. PubMed ID: 9262482
    [Abstract] [Full Text] [Related]

  • 7. The Shh signalling pathway in tooth development: defects in Gli2 and Gli3 mutants.
    Hardcastle Z, Mo R, Hui CC, Sharpe PT.
    Development; 1998 Aug 22; 125(15):2803-11. PubMed ID: 9655803
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor.
    Sasai K, Romer JT, Kimura H, Eberhart DE, Rice DS, Curran T.
    Cancer Res; 2007 Apr 15; 67(8):3871-7. PubMed ID: 17413002
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice.
    Zurawel RH, Allen C, Wechsler-Reya R, Scott MP, Raffel C.
    Genes Chromosomes Cancer; 2000 May 15; 28(1):77-81. PubMed ID: 10738305
    [Abstract] [Full Text] [Related]

  • 12. Several PATCHED1 missense mutations display activity in patched1-deficient fibroblasts.
    Bailey EC, Milenkovic L, Scott MP, Collawn JF, Johnson RL.
    J Biol Chem; 2002 Sep 13; 277(37):33632-40. PubMed ID: 12072433
    [Abstract] [Full Text] [Related]

  • 13. Expression of the PTCH1 tumor suppressor gene is regulated by alternative promoters and a single functional Gli-binding site.
    Agren M, Kogerman P, Kleman MI, Wessling M, Toftgård R.
    Gene; 2004 Apr 14; 330():101-14. PubMed ID: 15087129
    [Abstract] [Full Text] [Related]

  • 14. Differential requirement for Gli2 and Gli3 in ventral neural cell fate specification.
    Motoyama J, Milenkovic L, Iwama M, Shikata Y, Scott MP, Hui CC.
    Dev Biol; 2003 Jul 01; 259(1):150-61. PubMed ID: 12812795
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase 6 represents a novel drug target in the oncogenic Hedgehog signaling pathway.
    Dhanyamraju PK, Holz PS, Finkernagel F, Fendrich V, Lauth M.
    Mol Cancer Ther; 2015 Mar 01; 14(3):727-39. PubMed ID: 25552369
    [Abstract] [Full Text] [Related]

  • 16. Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma.
    Shahi MH, Afzal M, Sinha S, Eberhart CG, Rey JA, Fan X, Castresana JS.
    BMC Cancer; 2010 Nov 08; 10():614. PubMed ID: 21059263
    [Abstract] [Full Text] [Related]

  • 17. GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis.
    Hu MC, Mo R, Bhella S, Wilson CW, Chuang PT, Hui CC, Rosenblum ND.
    Development; 2006 Feb 08; 133(3):569-78. PubMed ID: 16396903
    [Abstract] [Full Text] [Related]

  • 18. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
    Kool M, Jones DT, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, Stark S, Hutter S, Seker-Cin H, Johann P, Bender S, Schmidt C, Rausch T, Shih D, Reimand J, Sieber L, Wittmann A, Linke L, Witt H, Weber UD, Zapatka M, König R, Beroukhim R, Bergthold G, van Sluis P, Volckmann R, Koster J, Versteeg R, Schmidt S, Wolf S, Lawerenz C, Bartholomae CC, von Kalle C, Unterberg A, Herold-Mende C, Hofer S, Kulozik AE, von Deimling A, Scheurlen W, Felsberg J, Reifenberger G, Hasselblatt M, Crawford JR, Grant GA, Jabado N, Perry A, Cowdrey C, Croul S, Zadeh G, Korbel JO, Doz F, Delattre O, Bader GD, McCabe MG, Collins VP, Kieran MW, Cho YJ, Pomeroy SL, Witt O, Brors B, Taylor MD, Schüller U, Korshunov A, Eils R, Wechsler-Reya RJ, Lichter P, Pfister SM, ICGC PedBrain Tumor Project.
    Cancer Cell; 2014 Mar 17; 25(3):393-405. PubMed ID: 24651015
    [Abstract] [Full Text] [Related]

  • 19. Expression patterns of hedgehog signaling peptides in naturally acquired equine osteochondrosis.
    Semevolos SA, Strassheim ML, Haupt JL, Nixon AJ.
    J Orthop Res; 2005 Sep 17; 23(5):1152-9. PubMed ID: 16140195
    [Abstract] [Full Text] [Related]

  • 20. Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma.
    Regl G, Neill GW, Eichberger T, Kasper M, Ikram MS, Koller J, Hintner H, Quinn AG, Frischauf AM, Aberger F.
    Oncogene; 2002 Aug 15; 21(36):5529-39. PubMed ID: 12165851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.